From the Editors of Pharmaceutical Executive

You are receiving this email as a subscriber to Pharmaceutical Executive

Interested in Learning About Other Topics' Give us your ideas for a Future Webcast or Podcast

*Webcasts:*
Marketing With Power to Nurse Practitioners and Physician Assistants Wednesday, February 9, 2011 11:00am EST Nurse Practitioners and Physician Assistants. Who are they? Where are they? What makes them tick? What do they want from you? What are the changes you will see in the professions in the coming years? These are just some of the things you will learn during this compelling and important webinar presented by 30 year pharma industry executive, Spencer Falk, MBA and 35 year Physician Assistant and industry executive David Mittman.
» Register Free!	Sponsored by: Clinician 1 & PANPharma

ON DEMAND Maximizing Brand Performance by Understanding the Degree of Influence Payers and Patients Have on Rx Dispensing at the Point of Purchase The interplay between patients and payers at the pharmacy counter is a largely unknown space. Patients walk into a pharmacy with a Rx for a particular branded product in hand, but may walk out with either a different branded Rx or a generic, or may even walk out empty handed. The gap is often referred to as 'prescription leakage' and is primarily influenced by payer controls and the behaviors of patients during the point of purchase. As payers and patients continue to exert more influence on Rx performance, it is important to understand the degree of influence each has from a national level down to a local level in order to maximize brand performance. Wolters Kluwer Pharma Solutions will share two use cases on how clients are leveraging ProMetis', the industry's first multi-dimensional data and analytics platform, to uncover new market opportunities, identify 'high-value' practitioners, and improve resource allocation to help execute local level marketing strategies.
» Register Free!	Sponsored by: Wolters Kluwer

ON DEMAND Expediting Clinical Site Initiation and Streamlining Site Monitoring with Digital Signatures Managing the conduct of advanced clinical trials has become a key competitive differentiating factor for companies engaged in the commercialization of innovative medicines. Ensuring speed to market while complying with a growing burden of regulatory compliance requires extensive attention to ways that increase efficiency of the process, often using advanced information tools. In this live web event, we will discuss how one critical but often overlooked aspect of clinical trial and GCP quality and compliance processes - the use of standardized uniform digital based signature technologies - can improve trial performance and ultimately help companies reduce time spans and save money in the long course toward market authorization. Specifically, you will learn how digital signatures within the Clinical ecosystem can: Speed study and site initiations Automate site monitoring reporting Enhance investigator portals (CTMS) Streamline regulatory audits and submissions Create secure, compliant and legally enforceable source electronic records that are recognized by sponsor organizations and regulatory authorities Enable secure document exchange and electronic submissions
» Register Free!	Sponsored by: ARX

ON DEMAND Case Study Webcast: Take the Safe Path to creating ERP Value A new ERP "solution" can be a game changer for your organization, and surprisingly, its selection and implementation may not be as risky as you think. Learn the pitfalls encountered during customer ERP projects, from selection to support, and the actions required to minimize risk, including tips on: gaining and maintaining project support balancing budget, schedule and functionality going "under the covers" of your vendor's application and their implementation methodology determining when and how to implement business process changes
» Register Free!

ON DEMAND Implementing a Comprehensive Aggregate Spend and Disclosure Solution to Ensure Compliance with US and International Regulations Compliance with US laws that require disclosure of promotion, marketing and advertising expenses represent a growing cost and administrative burden for life sciences companies. In addition, anti-bribery laws, such as FCPA, and a trend towards global transparency require companies to think beyond just compliance with US regulations. Join us to discuss the current regulatory environment on promotion disclosure and the growing responsibilities for companies to be more transparent with their promotional expenses. Hear about best practices that your peers implement to ensure effective and compliant processes within their organization and avoid common pitfalls in compliance. And learn about cost effective solutions to ensure uniform compliance with state and aggregate reporting requirement rules, including data collection and analysis, security protections, report distribution and management, and technology applications.
» Register Free!	Sponsored by: Cegedim Relationship Management

Podcasts:

Emerging Pharma Leadership Awards 2010
Pharm Exec’s third annual Emerging Pharma Leadership Awards podcast series addresses a key issue facing the biopharma industry today and asks the hard question of what are the attributes of effective leadership in organizations that have no choice but to adapt to a changing market environment? Join us as ten winners discuss their thoughts on leadership today.

Sponsored by: Cegedim Relationship Management

Trends in Patient Access: How Health Reform, Cost of Care and Stakeholder Response Will Shape Pharmaceutical Product Utilization Questions abound over the impact that health reform and related measures will have on patients’ ability to receive the medications they want and need. Join us as we discuss what pharmaceutical manufacturers, payers, providers and patients are doing in response to this dynamic healthcare environment.
	Sponsored by: AmerisourceBergen Specialty Group
Trends in Assessing Internal and Outsourced Clinical Trial Costs and Resource Demand Join Reid Paul, Editor in Chief of Pharmaceutical Representative, Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Andy Grygiel, Vice President of Marketing and Product Management at ClearTrial, for Parts 1 and 2 of this podcast series as we discuss recent Tufts research on assessing clinical trial costs and resource demand. In Part 3 of the series, Molly Blake-Michaels, Director, Clinical Services at ClearTrial, will examines the pros and cons of the most widely used clinical trial forecasting and budgeting methods in use today by biopharmaceutical and medical device companies.
	Sponsored by: ClearTrial

Whitepapers:

Increasing Planning Efficiency in Clinical Development
This white paper explores current planning trends and challenges in clinical development, and presents solutions and best practices that biopharmaceutical and medical devices companies are utilizing to increase planning efficiency. Benefits of this greater efficiency include compressed clinical study timelines, as well as a reduction in study costs and risks.

» View Whitepaper